EP2953633

CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    5.2.2014
  • EP published:
    4.10.2017
  • EP application number:
    14748994.2
  • Max expiry date:
    4.2.2034
  • Title:
    CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE

Timeline

Today
5.2.2014EP application
4.10.2017EP Publication

Owner

  • Name:
    The Board of Trustees of the Leland Stanford Junior University
  • Address:
    Office of the General Counsel Building 170, 3rd Floor, Main Quad P.O. Box 20386, 94305-2038, Stanford, CA, US
  • Name:
    The United States of America, as represented by The Secretary, Department of Health and Human Services
  • Address:
    6011 Executive Boulevard Suite 325, MSC 7660, 20892-7660, Bethesda, Maryland, US
  • Name:
    The Regents of the University of California
  • Address:
    1111 Franklin Street, 12th Floor, 94607-5200, Oakland, CA, US

Inventor

  • Name:
    WEISKOPF, Kipp
  • Address:
    Menlo Park, California, US
  • Name:
    HASENKRUG, Kim J.
  • Address:
    Victor Montana, US
  • Name:
    STODDART, Cheryl.A.
  • Address:
    Pacifica,California, US
  • Name:
    MCCUNE, Joseph M.
  • Address:
    San Francisco,California, US
  • Name:
    WEISSMAN, Irving L.
  • Address:
    Stanford, California, US

Priority

  • Number:
    201361761133 P
  • Date:
    5.2.2013
  • Country:
    US

Classification

  • Categories:
    A61K 35/00, A61P 31/12

Upload documents